Please login to the form below
homecare
This page shows the latest homecare news and features for those working in and with pharma, biotech and healthcare.
PMEA 2021: A Celebration of Excellence in Patient Engagement
The winner of this award was the National Clinical Homecare Association (NCHA) and the National Homecare Medicines Committee (NHMC) with support from their sponsor Mednet Group. ... Their entry On the Front Line - Behind Extraordinary Achievement
Latest news
-
Pharma Brand Planners' Blog (Part 3)
The 10 strategic Ps are most often defined as: product (profile, packaging, formulation, dosing), place (distribution, homecare), promotional mix (which promotional channels and which patient/HCP/payer segments), price (and discounting,
-
Quantum Pharma confirms Clinigen takeover bid
The confirmation of Clinigen's interest in Quantum comes after the latter agreed the sale of its Biodose Services unit - a specialist in homecare dispensary and delivery services - to HealthNet Homecare
-
Innovating patient care
The need for this programme suggests in itself that the case is not universally recognised - clinical homecare did not appear in the NHS' 2014 Five Year Forward View, for example. ... Duncombe explains that the Christie's own in-house homecare delivery
-
Finalists revealed for Communiqué Awards 2016
by Virgo Health Education. for Novartis. Proving the case for clinical homecare.
-
Roche taps Qualcomm for remote health monitoring
This forms part of a greater philosophy in homecare - currently many remote patient monitoring and management tools still require patients to visit their doctors' surgeries or hospitals when they want to
More from news
Approximately 8 fully matching, plus 30 partially matching documents found.
Latest Intelligence
-
A new focus on patient-centricity through remote healthcare
On a larger scale, clients we work with have had to move with pace and ingenuity to meet patient needs by, for instance, supporting healthcare professionals (HCPs), hospital and homecare providers
-
Things are going to be different
What is most interesting, however, is the noticeable increase in the volume of pharma companies looking to extend homecare support as health systems have come under pressure.
-
Understanding the patient journey
Patients are akin to customers, and they are using a service, whether that is when booking an appointment with their district nurse, being diagnosed by a specialist or awaiting a homecare
-
Tackling the challenge of non-adherence
Some pharmaceutical companies are providing homecare programmes involving nurses administering medications directly to patients in their homes and uploading the information into digital portals, which clinicians can access for monitoring and
-
How AbbVie Care is putting patients at the centre
AbbVie Care aims to:. Co-ordinate seamless homecare and nurse support at home; joining up hospital and community services with the requisite accountability and governance to ensure quality outcomes.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Ashfield appoints new UK head of patient solutions
PMEA 2013 ‘Best Homecare Programme’ award.
-
Healthcare at Home promotes Prof Sir Jonathan Asbridge
He takes up the role of clinical director. Healthcare at Home, a UK-based clinical homecare provider, has appointed Prof Sir Jonathan Asbridge as its new clinical director. ... We are striving to be the most customer-driven clinical homecare company in
-
Former Bausch + Lomb CEO to lead Forest Labs
Homecare Corporation of America.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Understanding the role of provider collaboratives
patients out of hospital or enabling homecare – so the ability to map pathways at system level and look at costs for each part of the system, using real-world data, will
-
Covid-19: how is it affecting prescribing patterns?
An important driver for this is surely the NICE rapid response guidelines, which made it clear that vulnerable patients should be switched to oral or subcutaneous or homecare-based medications where
-
How has the pandemic reshaped the NHS in 2020?
Homecare. Covid-19 has created an urgent need to keep patients out of hospital where possible.
-
Harness the power of data to map new patient pathways
Pharma can also use this data to find out where treatment is being administered, which is particularly insightful in terms of determining the number and type of patients requiring homecare services, ... and therefore homecare drugs.
-
OLED Medical Technology Saving Patient’s Sight During COVID-19 Pandemic
The Noctura 400 sleep mask is an innovative non-invasive homecare monitored treatment for the most common cause of blindness in the western world.
More from PMHub
Approximately 0 fully matching, plus 21 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- 2023 PM Society Awards – winners announced
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- LEO Pharma enters clinical trial partnership with ICON
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Inizio appoints Stefanie Christmas as global head of DE&I
- Rare diseases: not so rare after all
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Locus Biosciences announces first patient treated in urinary tract infection trial
- MHRA to introduce new UK clinical trials framework
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Sanofi to acquire Provention Bio in deal worth $2.9bn
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- Inizio appoints Stefanie Christmas as global head of DE&I
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
